Pentwater Capital Management’s St Jude Medical STJ Stock Holding History

Pentwater Capital Management’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-691,000	Closed	-$55.4M	–	145
2016 Q4	$55.4M	Sell	691,000 -207,500	-23%	-$16.5M	0.71%	26
2016 Q3	$71.7M	Sell	898,500 -87,500	-9%	-$7.06M	0.66%	27
2016 Q2	$76.9M	Buy	+986,000	New	+$70.3M	1.03%	23

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Pentwater Capital Management's STJ Position: Q1 2017 in Review

Pentwater Capital Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 691,000 shares — an estimated $55.4M sold.

Pentwater Capital Management first reported a position in STJ in Q2 2016 and held it in 3 quarters. The position peaked at $76.9M in Q2 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

Pentwater Capital Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
Pentwater Capital Management sold 691,000 St Jude Medical shares in Q1 2017, an estimated $55.4M.
Pentwater Capital Management first reported a position in St Jude Medical in Q2 2016 and held it in 3 quarters.
Pentwater Capital Management's St Jude Medical position peaked at $76.9M in Q2 2016.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Pentwater Capital Management's 13F filing for Q1 2017, filed 15 May 2017.